URSOCHOL 250 MG
Therapeutic area
Gastro-Intestinal
Manufacturer
ABC FARMACEUTICI S.P.A., Italia
Visa Number
VN-22135-19
Issuing date
24/07/2019
Applicant company
TV TPI. LTD.
Active ingredient
Ursodeoxycholic acid
Indication
• Dissolution of non-opaque gallstones with normal gallbladder function.
• For the treatment of primary biliary cirrhosis (PBC)
• Hepatobiliar disorder associated with cystic fibrosis in children aged 6 years to less than 18 years
Dosage
N/A
Content
250mg
Shelf life
24
Dosage Form
Hard capsule
Package
50 Capsules/Box
